这是一篇来自已证抗体库的有关
人类 mesothelin的综述,是根据10篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合mesothelin 抗体。
mesothelin 同义词: MPF; SMRP
赛默飞世尔
domestic rabbit 单克隆(SP74) | - 免疫组化基因敲除验证; 人类; 1:50; 图 6a, 6b
- 免疫组化-石蜡切片; 人类; 1:50; 图 1b, 5b, 5c, 7a, 7b
| 赛默飞世尔 mesothelin抗体(Thermo Fisher, SP74)被用于被用于免疫组化基因敲除验证在人类样本上浓度为1:50 (图 6a, 6b) 和 被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 1b, 5b, 5c, 7a, 7b). Int J Mol Sci (2022) ncbi |
domestic rabbit 单克隆(SP74) | - 免疫细胞化学基因敲除验证; 人类; 1:50; 图 2e
- 免疫组化-石蜡切片; 人类; 1:50; 图 1e
- 免疫细胞化学; 人类; 1:50; 图 2e
| 赛默飞世尔 mesothelin抗体(Thermo Fisher, MA5-16378)被用于被用于免疫细胞化学基因敲除验证在人类样本上浓度为1:50 (图 2e), 被用于免疫组化-石蜡切片在人类样本上浓度为1:50 (图 1e) 和 被用于免疫细胞化学在人类样本上浓度为1:50 (图 2e). Oncogenesis (2020) ncbi |
小鼠 单克隆(5B2) | | 赛默飞世尔 mesothelin抗体(Thermo Fisher, MS-1320-S0)被用于被用于免疫组化-石蜡切片在人类样本上 (图 3f). JCI Insight (2018) ncbi |
小鼠 单克隆(5B2) | | 赛默飞世尔 mesothelin抗体(Labvision, MA5-11918)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:10 (图 2). Pathol Res Pract (2016) ncbi |
小鼠 单克隆(5B2) | | 赛默飞世尔 mesothelin抗体(Thermo Scientific, MS-1320)被用于被用于免疫组化在人类样本上浓度为1:30 (图 4b). Cancer Immunol Res (2015) ncbi |
艾博抗(上海)贸易有限公司
domestic rabbit 单克隆 | | 艾博抗(上海)贸易有限公司 mesothelin抗体(Abcam, ab133489)被用于被用于免疫组化在人类样本上浓度为1:200 (图 2a). Front Oncol (2022) ncbi |
domestic rabbit 单克隆(SP74) | | 艾博抗(上海)贸易有限公司 mesothelin抗体(Abcam, ab93620)被用于被用于免疫组化-石蜡切片在人类样本上 (图 1). J Clin Invest (2017) ncbi |
圣克鲁斯生物技术
小鼠 单克隆(G-1) | | 圣克鲁斯生物技术 mesothelin抗体(Santa Cruz, sc-271540)被用于被用于免疫印迹在人类样本上浓度为1:250 (图 3a). PLoS ONE (2017) ncbi |
Rockland Immunochemicals
小鼠 单克隆(MN-1) | | Rockland Immunochemicals mesothelin抗体(Rockland Immunochemicals, 200-301-A88)被用于被用于免疫印迹在人类样本上 (图 1c). Mol Cancer Ther (2016) ncbi |
徕卡显微系统(上海)贸易有限公司
小鼠 单克隆(5B2) | | 徕卡显微系统(上海)贸易有限公司 mesothelin抗体(Novocastra, 5B2)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:30. Hum Pathol (2014) ncbi |
Li Y, Tian W, Zhang H, Zhang Z, Zhao Q, Chang L,
et al. MSLN Correlates With Immune Infiltration and Chemoresistance as a Prognostic Biomarker in Ovarian Cancer. Front Oncol. 2022;12:830570
pubmed 出版商
Nunes M, Pacheco F, Coelho R, Leit xe3 o D, Ricardo S, David L. Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer. Int J Mol Sci. 2022;23:
pubmed 出版商
Coelho R, Ricardo S, Amaral A, Huang Y, Nunes M, Neves J,
et al. Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation. Oncogenesis. 2020;9:61
pubmed 出版商
Watanabe K, Luo Y, Da T, Guedan S, Ruella M, Scholler J,
et al. Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. JCI Insight. 2018;3:
pubmed 出版商
Smith T, Moffett H, Stephan S, Opel C, Dumigan A, Jiang X,
et al. Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors. J Clin Invest. 2017;127:2176-2191
pubmed 出版商
De Santi C, Vencken S, Blake J, Haase B, Benes V, Gemignani F,
et al. Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing. PLoS ONE. 2017;12:e0170999
pubmed 出版商
Awuah P, Bera T, Folivi M, Chertov O, Pastan I. Reduced Shedding of Surface Mesothelin Improves Efficacy of Mesothelin-Targeting Recombinant Immunotoxins. Mol Cancer Ther. 2016;15:1648-55
pubmed 出版商
Ibrahim D, Abouhashem N. Diagnostic value of IMP3 and mesothelin in differentiating pancreatic ductal adenocarcinoma from chronic pancreatitis. Pathol Res Pract. 2016;212:288-93
pubmed 出版商
Wang E, Wang L, Tsai C, Bhoj V, Gershenson Z, Moon E,
et al. Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors. Cancer Immunol Res. 2015;3:815-26
pubmed 出版商
Ordonez N, Sahin A. Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study. Hum Pathol. 2014;45:1529-40
pubmed 出版商